ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,498,000 | +11.8% | 12,350,000 | 0.0% | 0.27% | +2.6% |
| Q4 2016 | $9,386,000 | -6.8% | 12,350,000 | 0.0% | 0.26% | -13.4% |
| Q3 2016 | $10,073,000 | +1.6% | 12,350,000 | +8.8% | 0.31% | -9.7% |
| Q2 2016 | $9,917,000 | -1.5% | 11,350,000 | 0.0% | 0.34% | +8.0% |
| Q1 2016 | $10,066,000 | -23.4% | 11,350,000 | -0.7% | 0.31% | -24.2% |
| Q4 2015 | $13,139,000 | +31.5% | 11,425,000 | +3.2% | 0.41% | +21.1% |
| Q3 2015 | $9,995,000 | -2.0% | 11,075,000 | +9.9% | 0.34% | -11.9% |
| Q2 2015 | $10,201,000 | -1.1% | 10,075,000 | 0.0% | 0.39% | +9.6% |
| Q1 2015 | $10,314,000 | -12.3% | 10,075,000 | -1.5% | 0.35% | -19.0% |
| Q4 2014 | $11,765,000 | +10.9% | 10,225,000 | 0.0% | 0.44% | -1.1% |
| Q3 2014 | $10,608,000 | – | 10,225,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |